Results 181 to 190 of about 207,525 (262)

Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]

open access: yesFront Immunol
Wu C   +10 more
europepmc   +1 more source

Effective treatment with double filtration plasmapheresis (DEPP) and high dose intravenous gammaglobulin therapy in a pregnant systemic lupus erythematosus(SLE) patient.

open access: bronze, 1989
Motoki Toyama   +8 more
openalex   +2 more sources

Dysregulation of U12‐Type Splicing in Lupus Neutrophils

open access: yesArthritis &Rheumatology, Accepted Article.
Abstract. Objective Neutrophil dysfunction is a hallmark of systemic lupus erythematosus (SLE), but its molecular basis remains unclear. This study explores transcriptional and post‐transcriptional changes in low‐density granulocytes (LDGs), a proinflammatory neutrophil subset expanded in SLE, focusing on NADPH oxidase (Nox) function and minor intron ...
Luz P. Blanco   +11 more
wiley   +1 more source

Correction: Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]

open access: yesFront Immunol
Wu C   +10 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Telitacicept for systemic lupus erythematosus-associated peripheral neuropathy: a case report. [PDF]

open access: yesFront Immunol
Tan J   +8 more
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

open access: yesBMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang   +12 more
wiley   +1 more source

Calcinosis Cutis in a Patient With Systemic Lupus Erythematosus: A Case Report. [PDF]

open access: yesCureus
Osman Ahmed Osman M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy